NCT03072628

Brief Summary

Randomized controlled trial of electronic cigarettes with nicotine, without nicotine, nicotine inhaler, and sham-control on endothelial function, oxidative stress and sympathetic nerve activity

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
148

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 11, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 2, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 7, 2017

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

October 4, 2023

Status Verified

October 1, 2023

Enrollment Period

5.9 years

First QC Date

March 2, 2017

Last Update Submit

October 2, 2023

Conditions

Keywords

nicotinesympathetic nerve activityoxidative stress

Outcome Measures

Primary Outcomes (2)

  • Flow Mediated dilatation (FMD)

    FMD is a measure of endothelial function

    10 minutes after exposure

  • Heart rate variability (HRV)

    HRV is a measure of cardiac sympathetic tone

    10 minutes after exposure

Secondary Outcomes (1)

  • Paraoxonase (PON)

    ~30 minutes after exposure

Study Arms (4)

Nicotine: use e-cig with nicotine

EXPERIMENTAL

One time exposure to e-cig with nicotine

Other: e-cig with nicotine

no nicotine: use e-cig without nicotine

EXPERIMENTAL

One time exposure to e-cig without nicotine

Other: e-cig without nicotine

Nicotine inhaler: use a nictoine inhaler

EXPERIMENTAL

One time exposure to nicotine inhaler

Other: nicotine inhaler

Sham control

SHAM COMPARATOR

Use an empty e-cigarette

Other: sham control

Interventions

use an e-cig with nicotine for 30 minutes

Nicotine: use e-cig with nicotine

use an e-cig without nicotine for 30 minutes

no nicotine: use e-cig without nicotine

use a nicotine inhaler for 30 minutes

Nicotine inhaler: use a nictoine inhaler

use an empty e-cigarette for 30 minutes

Sham control

Eligibility Criteria

Age21 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy

You may not qualify if:

  • Cardiac disease
  • Respiratory disease
  • Diabetes mellitus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCaliforniaLA

Los Angeles, California, 90095, United States

Location

MeSH Terms

Conditions

Tobacco Use Disorder

Interventions

Electronic Nicotine Delivery SystemsNicotine

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Smoking DevicesManufactured MaterialsTechnology, Industry, and AgricultureSolanaceous AlkaloidsAlkaloidsHeterocyclic CompoundsPyridinesHeterocyclic Compounds, 1-Ring

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

March 2, 2017

First Posted

March 7, 2017

Study Start

January 11, 2017

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

October 4, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations